Cargando…
Anakinra for systemic onset juvenile idiopathic arthritis: experience as a second versus first line treatment
Autores principales: | Ricart, S, Calzada, J, Torrente, V, Bou, R, Anton, J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194547/ http://dx.doi.org/10.1186/1546-0096-9-S1-P190 |
Ejemplares similares
-
Anakinra treatment in patients with systemic-onset juvenil idiopathic arthritis: “The Valencia Experience”
por: Marvillet, I, et al.
Publicado: (2011) -
Efficacy and safety of TNF-alpha antagonists in children with juvenile idiopathic arthritis who started treatment under 4 years of age
por: Roca, Clara Giménez, et al.
Publicado: (2014) -
Long-term follow-up of systemic onset juvenile idiopathic arthritis patients treated with Anakinra
por: Gattorno, Marco, et al.
Publicado: (2011) -
One-year observation of leflunomide effectiveness and saftey in juvenile idiopathic arthritis : a clinical practice review (preliminary data)
por: Torrente-Segarra, V, et al.
Publicado: (2011) -
Clinical depiction, treatment and long term follow up characterization of a group of enthesitis related arthritis - juvenile idiopathic arthritis patients from a spanish pediatric tertiary hospital
por: Baldizon, Samuel Hernandez, et al.
Publicado: (2014)